
Alendronate
Alendronate is a weekly or daily bisphosphonate with strong trial evidence: in a Cochrane review of 11 trials in 12,068 postmenopausal women, 10 mg a day cut vertebral fractures by 45% and, in women who already had a fracture, hip and other fractures too. It only works if absorbed, so coffee and calcium taken with the dose are both rated high-severity interactions.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Postmenopausal women and men with osteoporosis, people on long-term steroid medicines with low bone density, and people with Paget's disease of bone, when a prescriber recommends it
Common dosing range
Set by your prescriber. The labels list 70 mg once weekly (or 10 mg daily) to treat osteoporosis in women and men, 35 mg weekly or 5 mg daily to prevent it, 5 mg daily (10 mg in postmenopausal women not on estrogen) for steroid-induced osteoporosis, and 40 mg daily for 6 months for Paget's disease
When to expect effects
The label says increases in bone density were seen as early as 3 months; fracture reductions in trials were measured over 3 to 4 years
Watch out for
Esophageal irritation and ulcers if it is not taken upright with a full glass of plain water. Not for people with esophagus problems that delay emptying, who cannot stay upright for 30 minutes, or who have low blood calcium. Rare jaw osteonecrosis and atypical thigh fractures
What is it
Alendronate is a prescription bisphosphonate, a medicine that slows bone loss. It is sold as generic alendronate sodium tablets, as Fosamax 70 mg tablets taken once a week, and as Binosto, a 70 mg effervescent tablet dissolved in water. The Fosamax label approves it to treat and prevent osteoporosis after menopause, to increase bone mass in men with osteoporosis, to treat osteoporosis caused by steroid (glucocorticoid) medicines, and to treat Paget's disease of bone. It has no boxed warning. Because the body absorbs less than 1% of each dose, how you take it matters: food, coffee, juice, mineral water and calcium can all block it.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
spine fractures in postmenopausal osteoporosis Strong Evidence | Large; about 45% fewer spine fractures | Postmenopausal women with osteoporosis, especially those with a prior spine fracture | Measured over 3 to 4 years |
hip and other fractures in women who already had a fracture Strong Evidence | Moderate to large in secondary prevention; not significant for hip and non-spine fractures in primary prevention | Postmenopausal women with a prior fracture or bone density in the osteoporosis range | Measured over 3 to 4 years |
osteoporosis in men Good Evidence | Spine density up 7.1% versus 1.8% on placebo | Men with osteoporosis, with or without low testosterone | Measured over 2 years |
bone loss from steroid (glucocorticoid) medicines Good Evidence | Spine density up 2.1% to 2.9% versus a 0.4% fall on placebo | Adults on long-term glucocorticoids with low bone density | Measured over 48 weeks |
continuing beyond 5 years for non-spine fractures Good Evidence | No difference in non-spine fractures; fewer clinical spine fractures when continued | Women who have completed about 5 years of alendronate | Measured over 5 additional years |
spine fractures in postmenopausal osteoporosis
- Effect
- Large; about 45% fewer spine fractures
- Best fit
- Postmenopausal women with osteoporosis, especially those with a prior spine fracture
- Time
- Measured over 3 to 4 years
hip and other fractures in women who already had a fracture
- Effect
- Moderate to large in secondary prevention; not significant for hip and non-spine fractures in primary prevention
- Best fit
- Postmenopausal women with a prior fracture or bone density in the osteoporosis range
- Time
- Measured over 3 to 4 years
osteoporosis in men
- Effect
- Spine density up 7.1% versus 1.8% on placebo
- Best fit
- Men with osteoporosis, with or without low testosterone
- Time
- Measured over 2 years
bone loss from steroid (glucocorticoid) medicines
- Effect
- Spine density up 2.1% to 2.9% versus a 0.4% fall on placebo
- Best fit
- Adults on long-term glucocorticoids with low bone density
- Time
- Measured over 48 weeks
continuing beyond 5 years for non-spine fractures
- Effect
- No difference in non-spine fractures; fewer clinical spine fractures when continued
- Best fit
- Women who have completed about 5 years of alendronate
- Time
- Measured over 5 additional years
Evidence for 5 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
spine fractures in postmenopausal osteoporosis
Disease adjunctA Cochrane review of 11 randomized trials in 12,068 postmenopausal women found that alendronate 10 mg a day lowered vertebral fractures by 45% (risk ratio 0.55), both in women without a prior fracture (about 2% absolute reduction) and in women with one (about 6%). In the Fracture Intervention Trial of 2,027 women aged 55 to 81 with low hip bone density and an existing spine fracture, new spine fractures on X-ray fell from 15.0% to 8.0% over 3 years, and painful (clinical) spine fractures from 5.0% to 2.3%. An earlier 3-year trial in 994 women found new spine fractures in 3.2% versus 6.2% on placebo.
Bottom line: Alendronate reliably cuts spine fractures in women with osteoporosis.
hip and other fractures in women who already had a fracture
Disease adjunctIn the Cochrane review, alendronate 10 mg a day lowered non-spine fractures by 23% and hip fractures by 53% (about 1% absolute) in women who already had a fracture (secondary prevention). For women without a prior fracture (primary prevention), the reductions in non-spine and hip fractures were not statistically significant. In the 4-year FIT arm of 4,432 women with low bone density but no spine fracture, clinical fractures fell 36% only in those with osteoporosis-range hip density, with no significant reduction in women with higher density.
Bottom line: The hip and non-spine fracture benefit is clearest in women who already have osteoporosis or a fracture.
Evidence is mixed
Primary-prevention results for hip and non-spine fractures were not statistically significant in the Cochrane review, and FIT found no clinical fracture reduction in women whose hip density was above the osteoporosis range.
osteoporosis in men
Biomarker supportIn a 2-year double-blind trial of 241 men aged 31 to 87 (mean 63) with osteoporosis, all given calcium and vitamin D, alendronate 10 mg a day raised spine bone density by 7.1% versus 1.8% on placebo and hip (femoral neck) density by 2.5%. Spine fractures on X-ray occurred in 0.8% versus 7.1%, and height loss was smaller (0.6 vs 2.4 mm). Men with other secondary causes of osteoporosis were excluded, and the trial was not designed around fractures.
Bottom line: Alendronate raises bone density in men with osteoporosis, and one trial also found fewer spine fractures.
bone loss from steroid (glucocorticoid) medicines
Biomarker supportTwo 48-week placebo-controlled trials enrolled 477 men and women aged 17 to 83 taking glucocorticoids. Spine bone density rose 2.1% on 5 mg and 2.9% on 10 mg a day, while it fell 0.4% on placebo; hip density also rose. New spine fractures were 2.3% versus 3.7%, a difference too small to be certain (relative risk 0.6, 95% CI 0.1 to 4.4). There was a small increase in nonserious stomach side effects on 10 mg.
Bottom line: Alendronate protects bone density in people on steroid medicines; a fracture benefit was not proven in these trials.
continuing beyond 5 years for non-spine fractures
No benefit foundIn the FLEX trial, 1,099 postmenopausal women who had taken alendronate for about 5 years were randomized to keep taking it (5 or 10 mg a day) or switch to placebo for 5 more years. Non-spine fractures did not differ (19% continuing vs 18.9% stopping; relative risk 1.00), and spine fractures seen only on X-ray were not significantly reduced (9.8% vs 11.3%). Women who continued had fewer clinically recognized spine fractures (2.4% vs 5.3%; relative risk 0.45), and bone density fell modestly in those who stopped. Fractures were an exploratory outcome; the main outcome was hip bone density.
Bottom line: After 5 years, many women can pause alendronate without more non-spine fractures, but this is a decision for your prescriber.
Evidence is mixed
Continuing did lower clinically recognized spine fractures (2.4% vs 5.3%), so women at high spine-fracture risk may still benefit.
How it works
How to take it
What to track
Bottom line: Your prescriber sets the dose; take it first thing with plain water only, stay upright, and wait at least 30 minutes before coffee, food, calcium or other medicines.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Irritation, erosions and ulcers of the esophagus, occasionally with bleeding and rarely narrowing or perforation. The label says the risk is higher in people who lie down after the dose, do not take it with a full glass of water, or keep taking it after symptoms start. Fosamax has no boxed warning.
Osteonecrosis of the jaw (bone damage in the jaw), mostly after tooth extraction or with infection, cancer, chemotherapy, steroids or poor dental health; the label says risk may rise with longer use.
Atypical fractures of the thigh bone with little or no trauma, sometimes in both legs, often preceded by weeks or months of dull thigh pain.
Low blood calcium can worsen, so it must be corrected before treatment, and severe, sometimes incapacitating bone, joint or muscle pain has been reported.
Who should avoid it
- People with esophagus abnormalities that delay emptying, such as stricture or achalasia (contraindicated)
- People who cannot stand or sit upright for at least 30 minutes (contraindicated)
- People with low blood calcium (hypocalcemia) or an allergy to any ingredient (contraindicated)
- People with creatinine clearance below 35 mL/min (not recommended), and children (not indicated)
Pregnancy & breastfeeding
Pregnancy: the Fosamax label says available data in pregnant women are not enough to show a drug-associated risk, and to stop it when pregnancy is recognized. Because bisphosphonates are stored in bone and released over years, the label says there is a potential risk of harm to the baby's skeleton even if pregnancy happens after a course of treatment has ended; how the time since stopping affects that risk has not been studied. Discuss pregnancy plans with your doctor. Breastfeeding: the label says it is not known whether alendronate is present in human milk or affects milk production or the breastfed infant, and that the benefits of breastfeeding should be weighed with the mother's need for the medicine.
Interactions
In bioavailability studies in postmenopausal women, black coffee taken with alendronate reduced the amount absorbed by about 60%, on top of an absorption that is already under 1%; orange juice did the same, and taking it with breakfast cut absorption by more than 85%. The label says to take it with plain water only and to wait at least 30 minutes before the first food or drink of the day. Have your coffee after that wait.
The label says calcium, antacids and oral medicines containing multivalent minerals interfere with alendronate absorption, and to wait at least 30 minutes after the dose before taking any other oral medicine. Calcium itself is still recommended when your diet is short of it, so take it later in the day, for example with a meal, and ask your pharmacist to set the timing.
The label says antacids and oral medications containing multivalent cations interfere with alendronate absorption. Take them no sooner than 30 minutes after alendronate, and ask your pharmacist about longer gaps for your other medicines.
In bioavailability studies done mainly in postmenopausal women, orange juice taken with alendronate reduced the amount absorbed by about 60%, on top of an absorption of only about 0.76% with water. The label says even dosing with orange juice markedly reduces absorption. Take alendronate with plain water only and have juice at least 30 minutes later.
The label says to take alendronate with plain water only, that other beverages (including mineral water) are likely to reduce its absorption, and not to take it with mineral water. No study has measured how much mineral water lowers absorption. Use plain tap or bottled water and wait at least 30 minutes before other drinks.
The label says oral products containing multivalent cations interfere with alendronate absorption, and iron is one of these minerals; no study has measured iron with alendronate. Take alendronate first with plain water and iron no sooner than 30 minutes later, the label's rule for other oral medicines; later in the day is simplest. Ask your pharmacist to set the timing.
The label says calcium, antacids and oral products containing multivalent cations interfere with alendronate absorption, and magnesium is one of these minerals; no study has measured magnesium with alendronate. Take alendronate first with plain water and magnesium no sooner than 30 minutes later, the label's rule for other oral medicines; later in the day is simplest.
The label says upper stomach and esophagus side effects were more common in people taking alendronate doses above 10 mg a day with aspirin products. In a 3-year trial where most people also used NSAIDs, side effects were similar to placebo, but the label still advises caution because NSAIDs irritate the stomach. Tell your prescriber if you use them regularly.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (6)
+ calcium
highCalcium and other multivalent minerals interfere with the absorption of alendronate, a drug that is already very poorly absorbed (under 1% of a dose taken with water on an empty stomach). The Fosamax label says taking it with calcium, antacids, or oral medications containing multivalent cations will interfere with absorption. Taken together, the calcium can leave the osteoporosis drug much less effective.
+ coffee
highCoffee (and orange juice) sharply reduce the absorption of alendronate, an oral bisphosphonate whose baseline absorption is already very low. Taking the tablet with coffee instead of plain water can cut the absorbed amount enough to make the dose ineffective for protecting bone.
+ iron
highAlendronate is barely absorbed (less than 1% of a dose), and its label says calcium, antacids and oral products containing multivalent minerals interfere with its absorption. Iron is a multivalent mineral, so taking it at the same time could lower the amount of alendronate absorbed and reduce protection for bone. The evidence is the label's statement for this group of minerals; no study has measured iron with alendronate.
+ magnesium
highAlendronate is barely absorbed (less than 1% of a dose), and its label says calcium, antacids and oral products containing multivalent minerals interfere with its absorption. Magnesium is a multivalent mineral and is found in many antacids, so taking it at the same time could lower the amount of alendronate absorbed and reduce protection for bone. The evidence is the label's statement for this group of minerals; no study has measured magnesium with alendronate.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I drink coffee with alendronate?⌄
Not with the dose. Black coffee lowered absorption by about 60% in studies, and this page rates coffee a high-severity interaction. Take alendronate with plain water only and wait at least 30 minutes, as the label says, before your coffee or breakfast.
Can I take my calcium supplement with alendronate?⌄
Not at the same time. The label says calcium and antacids interfere with absorption, and this page rates calcium a high-severity interaction. You may still need calcium; take it later in the day, such as with a meal, and ask your pharmacist to help with timing.
Can I take alendronate with mineral water or juice?⌄
The label says to take it with plain water only, and that other drinks, including mineral water, lower absorption. In absorption studies, orange juice taken with the dose cut absorption by about 60%. For Binosto, the label says to dissolve the tablet in plain room-temperature water, not mineral or flavored water.
Why do I have to stay upright after taking it?⌄
Alendronate can irritate the esophagus. The label says to swallow the tablet with a full glass of plain water and not to lie down for at least 30 minutes and until after your first food of the day. Stop and get medical advice if you develop pain or trouble swallowing, chest pain or new heartburn.
How long should I take alendronate?⌄
Your prescriber decides. The label says the best length of treatment is not known and that people at low fracture risk may be considered for stopping after 3 to 5 years. In the FLEX trial, stopping after 5 years did not raise non-spine fractures, but women who continued had fewer clinical spine fractures.
References by claim
spine fractures in postmenopausal osteoporosis
hip and other fractures in women who already had a fracture
Cummings et al., 1998 · PubMed (1998) link
osteoporosis in men
Orwoll et al., 2000 · PubMed (2000) link
bone loss from steroid (glucocorticoid) medicines
Saag et al., 1998 · PubMed (1998) link
continuing beyond 5 years for non-spine fractures
Black et al., 2006 · PubMed (2006) link
Safety
Fosamax (alendronate sodium) prescribing information · DailyMed (FDA label) link
Interaction: Coffee
Gertz et al., 1995 · PubMed (1995) link
Track Alendronate with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
